Actively Recruiting
Electronic Register on Advanced Heart Failure and Transplantation
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14
10000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are creating an electronic registry of patients diagnosed with Advanced Heart Failure or those who have had a Heart Transplant, tracking cases starting from January 1, 1985. This observational study aims to understand how often these conditions occur and to describe the characteristics of patients facing these serious heart conditions. The study looks at important outcomes like hospitalization due to heart-related causes and death over a five-year period. This study includes both past and ongoing data collection, reviewing information retrospectively and prospectively to gather a comprehensive view of patient experiences. Treatments for heart failure range widely, including medications, lifestyle changes, device implants, and heart transplant surgeries. The study does not assign treatments but collects detailed patient information to evaluate the impact of these approaches and disease progression. Participants will be regularly monitored through their medical records to assess hospitalizations, death events, and other health-related factors like device implantations or need for additional therapies. The study tracks these outcomes over five years to better understand patient health and disease management. Participation involves data collection without altering usual care, and there is no maximum age limit for involvement.
CONDITIONS
Brief Title
Electronic Register on Advanced Heart Failure and Transplantation di Cuore
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Ability to provide informed consent
- Diagnosis of Advanced Heart Failure or Heart Transplant
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 5 years
Participants who have advanced heart failure or a heart transplant are observed over time to assess their health status and outcomes such as hospitalizations and survival.
Regular check-ups over 5 years
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
L
Luciano Potena, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here